Última Hora: "Preços dos combustíveis descem na segunda-feira - TVI24" Sat, 17 Nov 2018 22:18:09 GMT    "Viagem pelos tascos e papelarias que servem o correio dos CTT - Jornal de Negócios - Portugal" Sat, 17 Nov 2018 10:43:00 GMT    "CEO do Banco CTT: OE olha para défice mas é "pouco ambicioso" para empresas - Jornal de Negócios - Portugal" Sat, 17 Nov 2018 21:01:55 GMT    "7,2 milhões de utilizadores em Portugal utilizam Internet móvel - TugaTech" Sat, 17 Nov 2018 11:47:07 GMT    "As nossas democracias vão acabar? - Jornal de Negócios - Portugal" Thu, 15 Nov 2018 19:17:12 GMT   "" Sun, 18 Nov 2018 01:26:40 GMT    "Primeiro autocarro ?urbano eléctrico? da AveiroBus vai para a estrada no início da semana - Diário de Aveiro" Sat, 17 Nov 2018 06:02:16 GMT    "?Mário, o cativador?: o cognome do Ministro das Finanças segundo o PSD - Expresso" Sat, 17 Nov 2018 21:45:40 GMT    "Portuguesa Tonic App chega ao pódio mundial e ganha aconselhamento da Bayer - Jornal de Negócios - Portugal" Sat, 17 Nov 2018 17:04:00 GMT    "Morreu o dono de um carro com? 5,15 milhões de km! - Observador" Sat, 17 Nov 2018 18:23:00 GMT      Para mais notícias, clique aqui.

Área de Acesso
       
       
Lembrar Sempre 
(Login BolsaPT & Canal Forex)

Mostrar Notícias:
 Ver notícias de outros activos

Pesquisa de notícias relativas à acção Sepracor Inc. (ordenadas pela data):


Akebia Therapeutics and Keryx Biopharmaceuticals Announce Chairperson for Combined Company
Associated Press (press release)
Prior to these roles, Mr. Adams served in several Chief Executive Officer positions at leading specialty pharmaceutical companies including Kos Pharmaceuticals, Inc., Sepracor, Inc. and Inspire Pharmaceuticals, Inc. Mr. Adams has also held general ...

e mais »

Subspecialty Training in Adult Psychiatry: November 2018
Healio
Sponsorship Statement: This CME activity is jointly sponsored by AKH Inc., Advancing Knowledge in Healthcare and Psychiatric Annals. ... Faculty members report the following financial relationships: Andrew A. Nierenberg, MD, has disclosed the following ...


MSR Sports Desk

Desloratadine Market 2018 Size, Revenue, Recent Developments Products, Services and Solutions, Growth Rate by ...
MSR Sports Desk
Pfizer, Teva, Wante Pharmaceutical, Novartis India Limited, Mylan, Sepracor, Sandoz, Apollo Pharmaceuticals, GSK, Mayne Pharma Inc, Abhilasha Pharma Pvt, Abbott, Takeda, Schering-Plough, Nanjing Hicin Pharmaceutical, Hairui Pharmaceutical, Hainan ...


The Iowa DeltaChi

Global Desloratadine Market Outlook 2025: Top Companies, Trends ...
The Iowa DeltaChi
The Desloratadine Market research report is a professional and in-depth study on the current state also focuses on the major drivers and restraints for the key ...

e mais »

Global Allergy Treatment Market Is Segmented Into Seven Key Regions: North America, South America, Eastern ...
Digital Journal
... market are Allergy therapeutics, Allergopharma, Allergon AB, Alerpharma S.A, Allergan, Inc., Genentech Inc., Schering-Plough Corporation, McNeil Consumer Healthcare, Collegium Pharmaceutical, Inc., Meda Pharmaceuticals, Inc, Sepracor, Inc. and ...

e mais »

India Reporter

Asthma Medication Market Insights, Rising Trends and Global Demand 2018 to 2025
India Reporter
Top Leading Companies are: Dulera, QVAR, Glaxosmithkline plc, MAP Pharmaceuticals_Inc, Merck & Co. Inc, AstraZeneca plc, Roche Holdings Ltd, Genentech Inc, Sepracor, Inc, Schering-Plough Corp, Sanofi-Aventis, Theravance Inc. Inquire for Sample ...
Asthma Medication Market 2018-2023 with Strategic Trends Growth, RevenueCryptoNomists (press release)

todos os 22 artigos de notícias »

Find Market Research By Abhishek Budholiya (press release) (blog)

Allergy Treatment Market is Set to Experience Revolutionary Growth by 2026
Find Market Research By Abhishek Budholiya (press release) (blog)
... treatment market are Allergy therapeutics, Allergopharma, Allergon AB, Alerpharma S.A, Allergan, Inc., Genentech Inc., Schering-Plough Corporation, McNeil Consumer Healthcare, Collegium Pharmaceutical, Inc., Meda Pharmaceuticals, Inc, Sepracor, Inc.

e mais »

thebankingsector.com

Desloratadine Market 2018-2025 CAGR, Working Capital, Strategies, Manufacturers, Regions
thebankingsector.com
... SWOT, strategies, views, and competitive landscape. The companies profiled in the Desloratadine market report are Pfizer, Teva, Wante Pharmaceutical, Novartis India Limited, Mylan, Sepracor, Sandoz, Apollo Pharmaceuticals, GSK, Mayne Pharma Inc.


The Future Gadgets

Desloratadine Market Demand Analysis By Top Key Players Like and Others 2018-2025
The Future Gadgets
Top manufactures include for Desloratadine market such as: Pfizer, Teva, Wante Pharmaceutical, Novartis India Limited, Mylan, Sepracor, Sandoz, Apollo Pharmaceuticals, GSK, Mayne Pharma Inc, Abhilasha Pharma Pvt, Abbott, Takeda, Schering-Plough, ...


Latest Market Reports By Abhishek Budholiya (press release) (blog)

Allergy Treatment Market : Advanced Technologies & Growth Opportunities in Global Industry
Latest Market Reports By Abhishek Budholiya (press release) (blog)
... treatment market are Allergy therapeutics, Allergopharma, Allergon AB, Alerpharma S.A, Allergan, Inc., Genentech Inc., Schering-Plough Corporation, McNeil Consumer Healthcare, Collegium Pharmaceutical, Inc., Meda Pharmaceuticals, Inc, Sepracor, Inc.

e mais »

advertisingmarket24.com

Insight of Desloratadine Market 2023- Know Market Overview, Market Share, Size, Status and Vendor Landscape 2023
advertisingmarket24.com
Top Manufacturers: Pfizer, Teva, Wante Pharmaceutical?, Novartis India Limited, Mylan, Sepracor, Sandoz, Apollo Pharmaceuticals, GSK, Mayne Pharma Inc, Abhilasha Pharma Pvt, Abbott, Takeda, Schering-Plough, Nanjing Hicin Pharmaceutical, Hairui ...
Future of Desloratadine Market Share, Key Drivers, Major Manufacturers, Business Trends and Forecast 2023And More News

todos os 2 artigos de notícias »

thebusinesstactics.com

Global Asthma Medication Market Industry Growth Analysis, Outlook and Forecast till ? 2022
thebusinesstactics.com
The report provides a detailed Global Asthma Medication Industry Overview along with the analysis of industryâ??s gross margin, cost structure, consumption value, and sale price. The leading companies of the Global Asthma Medication Market, ...


Global Asthma Medication Market Analysis Report 2018-2025: Dulera, QVAR, Glaxosmithkline plc, MAP ...
Economic Daily Gazette (press release)
The global Asthma Medication market research report profiles numerous dominant market players such as Dulera, QVAR, Glaxosmithkline plc, MAP Pharmaceuticals,Inc, Merck & Co. Inc, AstraZeneca plc, Roche Holdings Ltd, Genentech Inc, Sepracor, Inc, ...


The Coconutoil Blog (blog)

Desloratadine Market Analysis, Growth Forecast Analysis by Manufacturers, Regions, Type and Application to 2025
The Coconutoil Blog (blog)
Pfizer, Teva, Wante Pharmaceutical, Novartis India Limited, Mylan, Sepracor, Sandoz, Apollo Pharmaceuticals, GSK, Mayne Pharma Inc, Abhilasha Pharma Pvt, Abbott, Takeda, Schering-Plough, Nanjing Hicin Pharmaceutical, Hairui Pharmaceutical, Hainan ...

e mais »

TokensJournal

Desloratadine market 2018 Product Type, Market price, Production Area , Analysis by Regions, Development Trend ...
TokensJournal
Pfizer, Teva, Wante Pharmaceutical, Novartis India Limited, Mylan, Sepracor, Sandoz, Apollo Pharmaceuticals, GSK, Mayne Pharma Inc, Abhilasha Pharma Pvt, Abbott, Takeda, Schering-Plough, Nanjing Hicin Pharmaceutical, Hairui Pharmaceutical, Hainan ...

e mais »

Desloratadine Market: Production, Revenue, Growth Rate, Price and Gross Margin
News Egypt (press release) (blog)
The report includes the most present industry improvements and new dispatches, which empower the clients to settle on their business choices and finish the principal execution for the development of business. The objectives of the Desloratadine Market ...

e mais »

Business Wire (press release)

Kala Pharmaceuticals Appoints Eric Trachtenberg as General Counsel and Corporate Secretary
Business Wire (press release)
Prior to Auxilium, he was Vice President, General Counsel and Corporate Secretary of Enobia Pharma, Inc. Prior to that, Mr. Trachtenberg served as Vice President and Associate General Counsel of Sepracor Inc. (now known as Sunovion Pharmaceuticals ...

e mais »

Desloratadine Market Research Report 2018 to 2025
India Reporter
... Wante Pharmaceutical, Novartis India Limited, Mylan, Sepracor, Sandoz, Apollo Pharmaceuticals, GSK, Mayne Pharma Inc, Abhilasha Pharma Pvt, Abbott, Takeda, Schering-Plough, Nanjing Hicin Pharmaceutical, Hairui Pharmaceutical, Hainan Poly Pharm ...

e mais »

Times of Jersey (press release) (blog)

Global Desloratadine Market Demand 2018- Pfizer, Teva, Wante Pharmaceutical, Novartis India Limited, Mylan ...
Times of Jersey (press release) (blog)
The well-established players in the market are Pfizer, Teva, Wante Pharmaceutical, Novartis India Limited, Mylan, Sepracor, Sandoz, Apollo Pharmaceuticals, GSK, Mayne Pharma Inc, Abhilasha Pharma Pvt, Abbott, Takeda, Schering-Plough, Nanjing Hicin ...


BSA bureau (press release)

Sumitomo Dainippon appoints Nomura as President & CEO
BSA bureau (press release)
In 2010, Sunovion (formerly Sepracor Inc.), was acquired by Sumitomo Dainippon. Nomura took the position of the Vice Chair, Executive Vice President and CFO, Sunovion Pharmaceuticals Inc. in 2012. Following 2014, he became associated with the ...

e mais »

TheTokenWire (press release)

Desloratadine Market 2018 Size, Application,Revenue, Types, Trends in Future, Scope to 2025
TheTokenWire (press release)
Pfizer, Teva, Wante Pharmaceutical, Novartis India Limited, Mylan, Sepracor, Sandoz, Apollo Pharmaceuticals, GSK, Mayne Pharma Inc, Abhilasha Pharma Pvt, Abbott, Takeda, Schering-Plough, Nanjing Hicin Pharmaceutical, Hairui Pharmaceutical, Hainan ...

e mais »

Business Wire (press release)

Kala Pharmaceuticals Strengthens Commercial Organization in Preparation for First Product Launch
Business Wire (press release)
BUSINESS WIRE)--Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the development and commercialization of product candidates using its proprietary mucus-penetrating particle (MPP) technology, today announced the ...


Business Wire (press release)

Entasis Therapeutics Appoints David C. Hastings to Board of Directors
Business Wire (press release)
BUSINESS WIRE)--Entasis Therapeutics Holdings Inc., a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, today announced the appointment of David C. Hastings to the company's Board of ...

e mais »

Arbutus Strengthens Management Team With Appointment of David C. Hastings as New Chief Financial Officer
GlobeNewswire (press release)
Mr. Hastings also previously served as Vice President, Chief Financial Officer and Treasurer of ArQule Inc. During his tenure at ArQule, he played an important role in ArQule's transition into a drug discovery and development organization, and in two ...


Tullahoma News and Guardian

Nautic Partners Announces Acquisition of Mikart, Inc.; Michael Kallelis Appointed as CEO
Business Wire (press release)
Mike has held senior roles at GE Life Sciences, Millipore and Sepracor, where he managed technologies directed at diagnostics, genomics, proteomics, bioprocessing and drug development. ?In Nautic, Mikart has found the ideal partner to continue scaling ...
Nautic Partners buys MikartPE Hub (blog)

todos os 9 artigos de notícias »

Business Wire (press release)

Rodin Therapeutics Expands Leadership Team, Adding Extensive Experience in Clinical and Business Development
Business Wire (press release)
She then joined Sunovion Pharmaceuticals, Inc. (formerly Sepracor), moving through positions of increasing responsibility into the role of vice president for corporate development and licensing. Sullivan played an instrumental role in the company's ...


Business Wire (press release)

BioClin Therapeutics Appoints Graeme Currie, Ph.D., as Chief Operating Officer and Esteban (Steve) Abella, MD, as ...
Business Wire (press release)
Dr. Currie has over 25 years of drug development experience in both pharmaceutical and biotechnology companies, having held senior leadership roles at Dynavax Technologies Corp., Regeneron Pharmaceuticals, Sepracor Inc. and PDL Biopharma.

e mais »

BittAsset

Desloratadine Market 2018-2025: Investigation of upstream crude materials and downstream interest
BittAsset
Top Manufacturers in Desloratadine Market reports are: Pfizer, Teva, Wante Pharmaceutical, Novartis India Limited, Mylan, Sepracor, Sandoz, Apollo Pharmaceuticals, GSK, Mayne Pharma Inc, Abhilasha Pharma Pvt, Abbott, Takeda, Schering-Plough, ...

e mais »

Sepracor Inc. to Become Sunovion Pharmaceuticals Inc.
Business Wire (press release)
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sepracor Inc. (Sepracor) and Dainippon Sumitomo Pharma Co., Ltd. (DSP), an Osaka, Japan-based pharmaceutical company, announced today the intent to change the Sepracor name to Sunovion ...

e mais »

Bellicum Pharmaceuticals Appoints Edmund P. Harrigan, MD to its Board of Directors
GlobeNewswire (press release)
In addition to his experience at Pfizer, Dr. Harrigan previously served as President & CEO of Karuna Pharmaceuticals, and in senior clinical leadership positions at Neurogen Corp. and Sepracor, Inc. Prior to entering the pharmaceutical industry in 1990 ...

e mais »

Largura do Site:

 Imagem de Fundo:

Copyright@1998-2018 - BolsaPT.com, todos os direitos reservados.
Fórum de Bolsa Cotações de Bolsa Notícias de Bolsa Chat de Bolsa Disclaimer Recursos para Webmasters